Universal reference book for medicines

Active substance: betamethasone, salicylic acid

Type: Anti-inflammatory and keratolytic drug for external use

Manufacturer: BELUPO, Pharmaceuticals & Cosmetics (Croatia)
Composition, form of production and packaging
? The solution for external use is transparent, colorless, viscous, with the smell of isopropanol.
1 g
betamethasone dipropionate 640 μg,
which corresponds to the content of betamethasone 500 μg
salicylic acid 20 mg
Excipients: disodium edetate - 0.3 mg, hypromellose 4000 cps - 5 mg, sodium hydroxide - 5 mg, isopropanol - 392 mg, water - 577.06 mg.
50 ml - bottles of high-density polyethylene with a dropper (1) - packs of cardboard.
100 ml - bottles of high-density polyethylene with a dropper (1) - packs of cardboard.
20 ml - bottles of high-density polyethylene with a spray pump mechanism (1) complete with a plastic nozzle-sprayer - packs of cardboard.
50 ml - bottles of high-density polyethylene with a spray pump mechanism (1) complete with a plastic nozzle-sprayer - packs of cardboard.
100 ml - bottles of high-density polyethylene with a spray pump mechanism (1) complete with a plastic nozzle-sprayer - packs of cardboard.
Description of the drug approved by the manufacturer for the printed edition of 2012.
The drug is for external use. Belosalik ® lotion has anti-inflammatory, antipruritic, anti-edematous, antiallergic, antiproliferative, immunosuppressive, keratolytic, antimicrobial, antifungal action.
Betamethasone dipropionate is a synthetic GCS, which has anti-inflammatory, antiallergic, antipruritic and vasoconstrictive effects. When applied to the skin surface, it narrows the vessels, relieves itching, reduces the release of inflammatory mediators (from eosinophils and mast cells), interleukins 1 and 2, interferon gamma (from lymphocytes and macrophages), inhibits the activity of hyaluronidase and reduces the permeability of the vascular wall. Interacts with specific receptors in the cytoplasm of the cell, stimulates the synthesis of mRNA, inducing the formation of proteins, including lipocortin, mediating cellular effects. Lipocortin depresses phospholipase A 2 , blocks the release of arachidonic acid and the biosynthesis of endoperoxides, prostaglandins, leukotrienes (contributing to the development of inflammation, allergy and other pathological processes).
Salicylic acid due to keratolytic action cleans lesions from scales, promotes the penetration of betamethasone into the skin, supports the acidic environment of the skin, preventing the development of bacterial and fungal infections.
Data on the pharmacokinetics of the preparation Belosalik® Lotion are not available.
Subacute and chronic dermatoses sensitive to GCS therapy, accompanied by hyperkeratosis and desquamation:
- psoriasis;
- seborrhea;
- seborrheic dermatitis (scalp);
- Asbestine ringworm;
- Neurodermatitis;
- red flat lichen with localization on the scalp;
- eczema;
- skin dyshidrosis;
The drug is intended for external use.
A few drops of the solution for external application are evenly distributed over the surface of the skin, slightly rubbing. Multiplicity of application - 2 times / day, in mild cases it is sufficient to use only once.
The duration of a continuous course of treatment is usually limited to 3-4 weeks. If a longer course of therapy is required, the drug should be used less frequently, for example, every other day.
The drug can be administered with caution to children from 6 months and as soon as possible.
Side effects, as a rule, are reversible and bear a weak character.
From the skin: it is possible to develop hypersensitivity reactions (itching, burning, hyperemia), acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, secondary skin infections.
With continuous continuous uncontrolled application and when applied to large areas of the skin: telangiectasia, systemic manifestations of side effects of GCS or salicylates.
When developing a hypersensitivity reaction or adverse reactions, the drug should be discontinued and consult a doctor.
- Tuberculosis of the skin;
- cutaneous manifestations of syphilis;
- chickenpox;
- viral skin infections;
- skin postvaccinal reactions;
- open wounds;
- trophic ulcers;
- rosacea;
- Acne vulgaris;
- Children's age up to 6 months;
- hypersensitivity to betamethasone, salicylic acid or to any of the auxiliary components of the drug.
Use of the drug Belosalik ® lotion in pregnant women is allowed in cases where the intended use for the mother exceeds the risk to the fetus. In such cases, the use of the drug should be short and limited to small areas of skin.
In the period of breastfeeding, the use of the drug Belosalik ® lotion is possible on strict indications, but the drug should not be applied to the skin of the breast before feeding.
Contraindicated in childhood up to 6 months.
Use of the drug Belosalik in children should be as short as possible while observing strict precautions, in children there is a risk of systemic absorption of a proportionally larger number of active components due to the prevalence of skin area over body weight and insufficient maturity of the epidermis. Do not use the drug in children under the bandages, and especially under plasticized diapers, which can increase the risk of developing unwanted phenomena.
The drug is intended for external use only.
Avoid contact with eyes and mucous membranes, as well as use of the drug in the anogenital area.
It is not recommended to use the drug under an occlusive dressing, except when it is necessary.
When developing fungal or bacterial microflora on the skin, it is necessary to use an additional antibacterial or antifungal agent.
The preparation Belosalik ® lotion in the form of a solution for external use is especially suitable for use on the scalp. The solution is easily distributed over the surface of the skin, does not adhere or dry the hair, leaves no visible traces, has a cooling effect on the skin.
Impact on the ability to drive vehicles and manage mechanisms
Data on the adverse effects of the drug Belosalik® Lotion on the ability to drive vehicles and mechanisms are not available.
Symptoms: manifestation of systemic side effects.
Treatment: it is recommended to cancel the drug and symptomatic therapy.
There was no clinically significant interaction with other drugs.
The simultaneous use of cosmetic and dermatological products for external use containing ethanol, or medical soap with a pronounced drying effect, can cause skin irritation.
The drug is approved for use as a means of OTC..
The drug should be stored out of reach of children at a temperature of no higher than 25 ° C. Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!